Recombinant Vibrio vulnificus Quinolinate synthase A (nadA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our default glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type will be determined during the production process. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
nadA; VV2272; Quinolinate synthase A; EC 2.5.1.72
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-353
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Vibrio vulnificus (strain YJ016)
Target Names
nadA
Target Protein Sequence
MSHILDKIDT VYPFPPKPIP LTQDEKAAYI ASIKQLLKEK DAVLIAHYYT DPEIQALAEE TGGFVGDSLE MAKFGNRHPA GTLIIAGVRF MGESAKILTP EKRILMPTLE AECSLDLGCP ADKFTEFCDA HPDHTVVVYA NTSAAVKARA DWVVTSSIAL EIVEHLDAED KPIIWGPDRH LGSYIANKTG ADMLLWQGEC VVHDEFSADA LRKMKAVYPD AAILVHPESP ASVVELADAV GSTSQLIKAA KELPQQKMIV ATDKGIFFKM QQLVPEKELI EAPTAGAGAT CRSCAHCPWM AMNGLKAIET ALREGGEQHE IFVDEALRVK SLIPLNRMLD FAEKLNMQVK GNV
Uniprot No.

Target Background

Function
Catalyzes the condensation of iminoaspartate with dihydroxyacetone phosphate to form quinolinate.
Database Links

KEGG: vvy:VV2272

Protein Families
Quinolinate synthase A family, Type 1 subfamily
Subcellular Location
Cytoplasm.

Q&A

How does temperature affect expression and activity of V. vulnificus proteins?

Temperature significantly impacts V. vulnificus protein expression and activity. Research on qnrVv demonstrates that cold shock (temperature downshift to 15°C) induces expression of various genes in V. vulnificus . Similarly, nadA expression may be regulated by temperature shifts that mimic environmental transitions. When designing experiments with recombinant nadA, researchers should consider temperature as a critical variable that may affect protein folding, stability, and enzymatic activity. Experimental protocols should include careful temperature controls and documentation of any temperature shifts during protein expression and purification .

What growth media and conditions are optimal for V. vulnificus studies?

For optimal growth of V. vulnificus cultures:

ParameterRecommended ConditionNotes
Temperature37°C for standard growthCold shock at 15°C can induce stress responses
MediaMarine broth or LB with 2-3% NaClV. vulnificus is halophilic
pH7.5-8.0Maintains optimal enzyme activity
OxygenAerobic conditionsMicroaerobic for some experiments
SupplementsIron may influence virulenceIron availability affects gene expression

When transitioning from experimental settings that mimic host conditions (37°C with bile salts) to environmental conditions (lower temperatures), growth rates may be significantly affected, as demonstrated in studies of V. vulnificus mutants . This environmental transition model may be valuable for studying nadA regulation under conditions that simulate the bacterial life cycle.

How should I design experiments to study nadA function in V. vulnificus?

Designing robust experiments for nadA functional studies requires careful consideration of multiple variables:

  • Create clear hypotheses based on preliminary research and existing literature

  • Identify appropriate independent and dependent variables

  • Establish suitable controls (positive, negative, and experimental)

  • Minimize experimental bias through blinding techniques

  • Ensure adequate sample sizes for statistical significance

When designing gene deletion experiments similar to those performed for qnrVv studies, construct single in-frame deletion mutants in nadA and potentially create double mutants with related genes to evaluate functional relationships . Test mutant strains under various environmental conditions (temperature, salinity, pH) and exposure to DNA-damaging agents to assess phenotypic changes 2.

What controls are essential when studying recombinant V. vulnificus proteins?

Essential controls for recombinant protein studies include:

  • Expression vector without insert (negative control)

  • Well-characterized recombinant protein with similar properties (positive control)

  • Wild-type V. vulnificus strain compared to nadA knockout strain

  • Complementation studies to verify phenotype restoration

  • Multiple biological replicates to ensure reproducibility

Experimental bias may arise when researchers are influenced by expected outcomes, especially when analyzing qualitative data2. To minimize bias, implement blind sample analysis techniques where the experimenter analyzing data is unaware of which conditions apply to which samples2. This approach is particularly important when assessing phenotypic changes resulting from nadA manipulation.

How can I validate that my recombinant nadA is properly folded and functional?

Validation of recombinant nadA structure and function should employ multiple complementary approaches:

  • Enzymatic activity assays measuring quinolinate production

  • Circular dichroism spectroscopy to assess secondary structure

  • Thermal shift assays to evaluate protein stability

  • Size exclusion chromatography to confirm oligomeric state

  • Complementation of nadA-deficient strains to verify functional rescue

Testing the recombinant protein under various environmental conditions, including temperature shifts and exposure to oxidative stress, can provide insights into its stability and function under conditions relevant to V. vulnificus lifecycle . Compare activity parameters to those of nadA from related bacterial species to establish benchmarks for proper folding and function.

What approaches should I use to study potential interactions between nadA and other V. vulnificus proteins?

To investigate protein-protein interactions involving nadA:

  • Co-immunoprecipitation with tagged nadA to identify binding partners

  • Bacterial two-hybrid systems to screen for interacting proteins

  • Surface plasmon resonance to measure binding kinetics

  • Cross-linking mass spectrometry to map interaction interfaces

  • Fluorescence resonance energy transfer (FRET) for in vivo interaction studies

Research on related V. vulnificus proteins suggests potential interactions between metabolic enzymes and stress response factors . When investigating whether nadA interacts with DNA repair mechanisms or stress response pathways, consider experimental designs that parallel those used in studies of qnrVv, which demonstrated connections between quinolone resistance genes and DNA damage responses .

How should I approach contradictory results in nadA expression studies?

When faced with contradictory results:

  • Systematically evaluate experimental variables that might explain differences

  • Assess the influence of strain variation on experimental outcomes

  • Consider environmental conditions that might affect gene regulation

  • Examine temporal factors, as expression patterns may vary with growth phase

  • Validate results using multiple orthogonal techniques

Studies of V. vulnificus gene expression show that environmental transitions can dramatically alter expression profiles . For instance, the transition from host-like conditions (37°C with bile salts) to environmental conditions (15°C) triggered differential expression patterns in qnrVv studies . Similar complex regulation might affect nadA expression, requiring careful consideration of experimental conditions when interpreting seemingly contradictory results.

What molecular detection methods are most reliable for studying V. vulnificus genes in various sample types?

Molecular detection methods for V. vulnificus genes vary in sensitivity and specificity:

MethodSensitivitySpecificityBest Sample TypeNotes
Conventional PCRModerateHighPure culturesLess affected by inhibitors
Real-time PCRHighVery highTissue samplesMedian 16,650 copies/mL in tissue
Nested PCRVery highModerateBlood samplesMay have false positives
RNA-seqHighHighAny (with proper processing)Provides expression context

Research indicates that tissue samples typically contain higher copy numbers of V. vulnificus DNA than blood samples (median 16,650 copies/mL vs. 638.5 copies/mL) . Additionally, tissue samples are less affected by short-term antibiotic administration, making them preferable for molecular detection when patients have received antimicrobial treatment . These considerations should be applied when designing experiments to detect and quantify nadA in various sample types.

What biosafety considerations apply to research with V. vulnificus and recombinant proteins?

V. vulnificus is a serious human pathogen requiring appropriate biosafety measures:

  • Conduct all work at Biosafety Level 2 (BSL-2) minimum

  • Use appropriate personal protective equipment (gloves, lab coat, eye protection)

  • Employ biosafety cabinets for procedures generating aerosols

  • Implement proper waste decontamination protocols

  • Develop and follow standard operating procedures for spills and exposures

V. vulnificus can cause three distinct clinical syndromes including overwhelming primary septicemia with case-fatality rates exceeding 50% . Researchers should be particularly vigilant if they have conditions that increase susceptibility to infection, such as chronic liver disease, alcoholism, or hematological disorders . Laboratory protocols should include provisions for immediate medical attention in case of potential exposure.

How might nadA research contribute to understanding V. vulnificus pathogenesis?

Research on V. vulnificus nadA could provide insights into pathogenesis through several mechanisms:

  • NAD metabolism may affect bacterial survival during host colonization

  • nadA regulation might be linked to virulence factor expression

  • Inhibition of nadA could represent a novel therapeutic target

  • Metabolic adaptations involving nadA might influence bacterial persistence

  • Host nutritional immunity could impact nadA function during infection

Studies of V. vulnificus virulence mechanisms have highlighted the importance of iron availability and bacterial metabolism in infection . Since NAD is central to bacterial energy metabolism, understanding nadA regulation and function could reveal how V. vulnificus adapts to changing environments during infection. Similar to findings with qnrVv, which was shown to be involved in responses to DNA damage and environmental stresses , nadA might contribute to bacterial adaptation to host conditions.

What approaches should I use to investigate nadA regulation in V. vulnificus?

To investigate nadA regulation:

  • Construct reporter gene fusions (e.g., nadA promoter-luciferase)

  • Perform chromatin immunoprecipitation to identify regulatory proteins

  • Use RNA-seq to assess transcriptional responses under various conditions

  • Conduct electrophoretic mobility shift assays to identify protein-DNA interactions

  • Create regulatory gene knockouts to assess their impact on nadA expression

Research on V. vulnificus gene regulation has revealed complex control mechanisms, including repressor proteins like NanR that regulate gene expression in response to environmental signals . Similar regulatory mechanisms might control nadA expression, potentially involving both repression under standard conditions and induction during specific environmental transitions or stresses .

How can I effectively design research questions to study nadA function?

Effective research questions about nadA should be:

  • Focused on a single aspect of nadA function or regulation

  • Researchable using available techniques and resources

  • Feasible within practical constraints of time and resources

  • Specific enough to be thoroughly answered

  • Complex enough to warrant in-depth investigation

  • Relevant to broader understanding of bacterial metabolism or pathogenesis

For example, rather than asking "What does nadA do in V. vulnificus?", a more effective research question would be "How does temperature downshift affect nadA expression and enzymatic activity in V. vulnificus, and what regulatory factors mediate this response?" This approach allows for more focused experimental design and clearer interpretation of results.

What emerging techniques might advance nadA research in V. vulnificus?

Emerging techniques with potential to advance nadA research include:

  • CRISPR-Cas9 genome editing for precise genetic manipulation

  • Single-cell RNA-seq to assess heterogeneity in nadA expression

  • Cryo-electron microscopy for high-resolution structural studies

  • Metabolomics to assess the impact of nadA activity on bacterial metabolism

  • Systems biology approaches to integrate nadA function into broader metabolic networks

These advanced techniques could help resolve questions about nadA structure-function relationships, regulatory mechanisms, and contribution to bacterial fitness under various environmental conditions, similar to how molecular techniques have enhanced understanding of qnrVv function in stress responses and antibiotic resistance .

How might nadA research inform development of novel therapeutic approaches?

Research on nadA could inform therapeutic development through several avenues:

  • Identification of nadA inhibitors as potential antimicrobial agents

  • Understanding of NAD metabolism as a vulnerability in bacterial physiology

  • Development of attenuated strains for vaccine research

  • Insights into bacterial adaptation that could inform combination therapies

  • Biomarker development for improved diagnosis of V. vulnificus infection

Current treatments for V. vulnificus infections include third-generation cephalosporins with doxycycline or quinolones . Research on nadA could potentially identify new therapeutic targets or improve understanding of bacterial responses to existing antibiotics. Similar to studies of quinolone resistance genes, which have revealed unexpected connections to stress responses , nadA research might uncover novel aspects of bacterial physiology that could be exploited for therapeutic purposes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.